Growth Metrics

Mannkind (MNKD) Net Margin (2010 - 2026)

Mannkind (MNKD) reported Net Margin of 18.43% for Q1 2026, down 3522.0% year-over-year from 0.54% in Q1 2025, and up 1.26% on a QoQ basis from 18.67% in Q4 2025.

Mannkind (MNKD) has 14 years of Net Margin data on file, last reported at 18.43% in Q1 2026.

  • Quarterly Net Margin fell 3522.0% year-over-year to 18.43% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 8.0% (down 1812.0% YoY) and the FY2025 annual result came in at 0.26%, down 940.0% from the prior year.
  • Net Margin improved to 18.43% in Q1 2026 per MNKD's latest filing, from 18.67% in the prior quarter.
  • Across five years, Net Margin topped out at 16.79% in Q1 2025 and bottomed at 9674.33% in Q2 2022.
  • The 5-year median for Net Margin is 2.78% (2024), against an average of 587.1%.
  • The widest annual swing landed in 2022, when Net Margin tumbled 952174 bps; it then soared 966350 bps in 2023.
  • Tracing MNKD's Net Margin over 5 years: stood at 49.77% in 2022, then jumped by 105 bps to 2.41% in 2023, then jumped by 301 bps to 9.66% in 2024, then plunged by 293 bps to 18.67% in 2025, then grew by 1 bps to 18.43% in 2026.
  • Per Business Quant, the three latest MNKD Net Margin figures stand at 18.43% (Q1 2026), 18.67% (Q4 2025), and 9.72% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.82%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 34.53%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 20.17%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 17.65%
10 Mannkind 1.09 Bn 956.66 Mn 82.66 Mn -18.43%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -18.43%
Dec 31, 2025 -18.67%
Sep 30, 2025 9.72%
Jun 30, 2025 0.87%
Mar 31, 2025 16.79%
Dec 31, 2024 9.66%
Sep 30, 2024 16.48%
Jun 30, 2024 -2.78%
Mar 31, 2024 16.04%
Dec 31, 2023 2.41%
Sep 30, 2023 6.98%
Jun 30, 2023 -10.83%
Mar 31, 2023 -24.11%
Dec 31, 2022 -49.77%
Sep 30, 2022 -43.97%
Jun 30, 2022 -9,674.33%
Mar 31, 2022 -216.79%
Dec 31, 2021 -224.22%
Sep 30, 2021 -19.93%
Jun 30, 2021 -152.59%
Mar 31, 2021 -74.08%
Dec 31, 2020 -143.20%
Sep 30, 2020 -73.31%
Jun 30, 2020 -5,126.00%
Mar 31, 2020 -57.42%
Dec 31, 2019 -83.81%
Sep 30, 2019 -1,481.43%
Jun 30, 2019 -6,193.50%
Mar 31, 2019 -85.30%
Dec 31, 2018 -45.06%
Sep 30, 2018 -540.79%
Jun 30, 2018 -582.46%
Mar 31, 2018 -876.91%
Dec 31, 2017 1,785.76%
Sep 30, 2017 -1,609.69%
Jun 30, 2017 -1,633.80%
Mar 31, 2017 -542.51%
Dec 31, 2016 435.13%
Sep 30, 2016 77.93%
Sep 30, 2012 -122,382.86%
Mar 31, 2011 -83,050.00%
Jun 30, 2010 -45,431.18%